Franz A. Duca

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 103 publications

Prognostic Thresholds of Tricuspid Regurgitation in Transthyretin Amyloid Cardiomyopathy.

Prognostic Thresholds of Tricuspid Regurgitation in Transthyretin Amyloid Cardiomyopathy.

Journal: JAMA cardiology

Published: August 31, 2026

Validation of an Artificial Intelligence-Derived ECG Algorithm for Detecting Cardiac Amyloidosis in Patients With Heart Failure With Preserved Ejection Fraction: Clinical Application and Prognostic Implications.

Validation of an Artificial Intelligence-Derived ECG Algorithm for Detecting Cardiac Amyloidosis in Patients With Heart Failure With Preserved Ejection Fraction: Clinical Application and Prognostic Implications.

Journal: Journal of the American Heart Association

Published: August 20, 2026

Association of Mitral Annular Disjunction on Magnetic Resonance Imaging With Cardiovascular Outcomes.

Association of Mitral Annular Disjunction on Magnetic Resonance Imaging With Cardiovascular Outcomes.

Journal: European journal of clinical investigation

Published: April 18, 2026

Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathy.

Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathy.

Journal: Scientific reports

Published: February 02, 2026

Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort.

Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort.

Journal: Journal of clinical medicine

Published: January 26, 2026

CMR-derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis.

CMR-derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis.

Journal: European journal of clinical investigation

Published: December 22, 2025

Sex-Specific Differences in Patients with Hypertrophic Cardiomyopathy: A Cohort Study from Vienna.

Sex-Specific Differences in Patients with Hypertrophic Cardiomyopathy: A Cohort Study from Vienna.

Journal: Journal of personalized medicine

Published: December 09, 2025

Insights into the renin-angiotensin-aldosterone system in transthyretin amyloid cardiomyopathy.

Insights into the renin-angiotensin-aldosterone system in transthyretin amyloid cardiomyopathy.

Journal: European journal of heart failure

Published: December 01, 2025

Coronary Artery Disease in Cardiac Amyloidosis: Prevalence, Clinical Relevance, and Cardiac Magnetic Resonance Imaging Features.

Coronary Artery Disease in Cardiac Amyloidosis: Prevalence, Clinical Relevance, and Cardiac Magnetic Resonance Imaging Features.

Journal: Journal of clinical medicine

Published: October 24, 2025

Impact of disease-modifying therapy on [99mTc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligence.

Impact of disease-modifying therapy on [99mTc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligence.

Journal: European journal of nuclear medicine and molecular imaging

Published: September 05, 2025

Additive diagnostic value of thoracic SPECT/CT imaging in perugini grade 1 patients who underwent bone scintigraphy.

Additive diagnostic value of thoracic SPECT/CT imaging in perugini grade 1 patients who underwent bone scintigraphy.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 13, 2025

Applicability of phase 3 trial selection criteria to real-world transthyretin amyloid cardiomyopathy patients.

Applicability of phase 3 trial selection criteria to real-world transthyretin amyloid cardiomyopathy patients.

Journal: Scientific reports

Published: June 10, 2025

Showing 1-12 of 103

Last Updated: 09/26/2026